Announced
Completed
Financials
Tags
regulatory consultancy
Completed
Friendly
Single Bidder
international consultancy
United Kingdom
Management Consulting
Acquisition
Majority
Private Equity
Domestic
Private
Synopsis
Eliquent Life Sciences, a global regulatory consulting firm for the life sciences industry, completed the acquisition of RApport Global Strategic Services, a UK based international regulatory consultancy. Financial terms were not disclosed. “Today’s announcement further positions ELIQUENT as a leader in global regulatory consulting and underscores our commitment to delivering value to our clients. I look forward to partnering with the talented RApport team as we offer our clients an expanded portfolio of solutions designed to streamline market entry and compliance strategies worldwide,” Tim Dietlin, ELIQUENT Life Sciences CEO.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.